Sion­na li­cens­es clin­i­cal-stage cys­tic fi­bro­sis as­sets from Ab­b­Vie short­ly af­ter large Se­ries C

Sion­na Ther­a­peu­tics snagged the ex­clu­sive world­wide li­cense to three of Ab­b­Vie’s cys­tic fi­bro­sis drug can­di­dates as the biotech aims to beef up its work in …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER